tiprankstipranks
Trending News
More News >
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market

Sun Pharmaceutical Industries Limited (SUNPHARMA) Income Statement

Compare
8 Followers

Sun Pharmaceutical Industries Limited Income Statement

Last quarter (Q1 2026), Sun Pharmaceutical Industries Limited's total revenue was ₹138.51B, an increase of 9.47% from the same quarter last year. In Q1, Sun Pharmaceutical Industries Limited's net income was ₹22.79B. See Sun Pharmaceutical Industries Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 525.78B₹ 484.97B₹ 438.86B₹ 386.54B₹ 334.98B
Gross Profit
₹ 410.20B₹ 370.55B₹ 325.67B₹ 277.78B₹ 242.80B
Operating Expenses
₹ 132.05B₹ 126.30B₹ 106.63B₹ 94.87B₹ 90.07B
Depreciation and Amortization
₹ 23.62B₹ 23.56B₹ 23.46B₹ 19.98B₹ 19.17B
EBITDA
₹ 149.68B₹ 128.76B₹ 116.51B₹ 101.54B₹ 83.45B
Operating Income
₹ 278.15B₹ 244.24B₹ 219.04B₹ 182.91B₹ 152.73B
Other Income/Expenses
₹ -140.78B₹ -133.75B₹ -125.44B₹ -138.27B₹ -124.86B
Pretax Income
₹ 137.37B₹ 110.49B₹ 93.61B₹ 44.65B₹ 27.87B
Net Income
₹ 109.29B₹ 95.76B₹ 84.74B₹ 32.73B₹ 29.04B
Per Share Metrics
Basic EPS
₹ 45.60₹ 39.91₹ 35.32₹ 13.64₹ 12.10
Diluted EPS
₹ 45.60₹ 39.91₹ 35.32₹ 13.64₹ 12.10
Weighted Average Shares Outstanding
2.40B 2.40B 2.40B 2.40B 2.40B
Weighted Average Shares Outstanding (Diluted)
2.40B 2.40B 2.40B 2.40B 2.40B
Currency in INR

Sun Pharmaceutical Industries Limited Earnings and Revenue History